Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2347 (LINC02347) is a long non-coding RNA (lncRNA) and specifically a long intergenic non-coding RNA (lincRNA). LincRNAs are more than 200 nucleotides in length and do not overlap with protein-coding genes. LINC02347 does not encode a protein product. The general class of lincRNAs is known to be involved in various regulatory processes, such as chromatin remodeling, regulation of transcription, RNA stabilization, and sometimes enhancer-like activities. While many lincRNAs are recognized as important regulators of gene expression and can play roles in diseases (such as cancer), current search results do not provide direct evidence or detailed functional studies for the disease relevance, specific biological functions, or therapeutic targetability of LINC02347 itself[1][3][5]. Therefore, LINC02347 should be classified as a non-coding RNA gene with regulatory potential, but there is no direct evidence at present to consider it a therapeutic target or a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2347 (LINC02347).